MSC-derived sEVs enhance patency and inhibit calcification of synthetic vascular grafts by immunomodulation in a rat model of hyperlipidemia

Y Wei, Y Wu, R Zhao, K Zhang, AC Midgley, D Kong… - Biomaterials, 2019 - Elsevier
Vascular grafts often exhibit low patency rates in clinical settings due to the pathological
environment within the patients requiring the surgery. Mesenchymal stem cell (MSC) …
被引用次数：113 相关文章

MSC-derived sEVs enhance patency and inhibit calcification of synthetic vascular grafts by immunomodulation in a rat model of hyperlipidemia

Y Wei, Y Wu, R Zhao, K Zhang, AC Midgley… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Vascular grafts often exhibit low patency rates in clinical settings due to the pathological
environment within the patients requiring the surgery. Mesenchymal stem cell (MSC) …

[引用][C] MSC-derived sEVs enhance patency and inhibit calcification of synthetic vascular grafts by immunomodulation in a rat model of hyperlipidemia

Y Wei, Y Wu, R Zhao, K Zhang, AC Midgley, D Kong… - Biomaterials, 2019 - cir.nii.ac.jp
MSC-derived sEVs enhance patency and inhibit calcification of synthetic vascular grafts by
immunomodulation in a rat model of hyperlipidemia | CiNii Research CiNii 国立情報学研究所 …

MSC-derived sEVs enhance patency and inhibit calcification of synthetic vascular grafts by immunomodulation in a rat model of hyperlipidemia.

Y Wei, Y Wu, R Zhao, K Zhang, AC Midgley, D Kong… - Biomaterials, 2019 - europepmc.org
MSC-derived sEVs enhance patency and inhibit calcification of synthetic vascular grafts by
immunomodulation in a rat model of hyperlipidemia. - Abstract - Europe PMC Sign in | Create …

[引用][C] MSC-derived sEVs enhance patency and inhibit calcification of synthetic vascular grafts by immunomodulation in a rat model of hyperlipidemia

Y Wei, Y Wu, R Zhao, K Zhang, AC Midgley, D Kong… - 2019